Document:

EX-10.2(c)

 Exhibit 10.2(c) 

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 
 SECOND AMENDMENT TO STELLAR MANUFACTURING 

AGREEMENT 
 This Second Amendment to
Stellar Manufacturing Agreement (“Second Amendment”) is entered into effective as of January 1, 2016 (“Effective Date”), by and between Stellar Technologies, Inc., a Minnesota corporation (“Stellar”) and Nevro Corp., a
Delaware corporation, having a place of business at 1800 Bridge Parkway, Redwood City, CA 94065 (“Customer”) (Stellar and Customer are the “Party[ies]”), relating to the Stellar Manufacturing Agreement entered into between the
Parties, dated July 1, 2009 (“2009 Agreement”) and First Amendment to Stellar Manufacturing Agreement, dated July 1, 2014 (“First Amendment”) (2009 Agreement and First Amendment, collectively the “Agreement”). 

In consideration of the mutual covenants contained in this Agreement, the receipt and sufficiency of which are hereby acknowledged, Customer and Stellar agree
as follows: 
 1.) Defined Terms. Except as otherwise defined in this Second Amendment, all defined terms in the Agreement shall
have the same meaning in this Second Amendment. 
 2.) Adoption of Terms of Agreement. Except as modified by this Second
Amendment, the Parties hereby adopt and restate all of the terms of: (a) the 2009 Agreement, as modified by the First Amendment, and (b) the terms of the First Amendment. 

3.) Section 2 of the First Amendment. Section 2 of the First Amendment is hereby deleted in its entirety and replaced with the
following: 
 “Customer hereby appoints Stellar as its primary supplier of all Products listed in Exhibit A, attached (and as
revised in Section 5 of this Second Amendment), and all related Services that Customer orders from Stellar during the Contract Term. All pricing related to the Products will be listed in the Price Schedule listed in the attached Exhibits B, B-1 and
B-2. All plans, designs and specifications used by Stellar in providing any Products, which are designed solely by Customer, are owned exclusively by Customer. Customer agrees to indemnify and hold Stellar harmless from any claims, judgments,
penalties, recalls and attorney fees arising from any third-party allegations that Customer’s plans, designs and specifications for the Products infringe on or violate any third party’s patents, trade secrets, proprietary rights or other
intellectual property rights. Stellar agrees to indemnify and hold Customer harmless from any claims, judgments, penalties, recalls, and/or attorney fees and costs arising from any third-party allegations that any of Stellar’s manufacturing
operations, processes, know-how, plans, designs, and/or specifications for the Products or Services infringe on or violate any third party’s patents, trade secrets, proprietary rights or other intellectual property rights. Such
“Intellectual Property Indemnification Rights” shall survive the expiration or termination of this Agreement. Stellar will cooperate with Customer’s efforts to obtain regulatory approval for its Products from governmental
authorities (‘Regulatory Approvals’) without conveying to Customer or any governmental authorities any right, title or interest in its Confidential Information and Intellectual Property as defined herein.” 

 4.) Section 5 of the First Amendment. Section 5 of the First Amendment is hereby
deleted in its entirety and replaced with the following: 
 “Minimum Purchase Requirement, Purchase Orders and Purchase Order
Acknowledgements. During each of the following Contract Years, Customer shall purchase from Stellar the following percentages of its requirements for each of the Key Products and Supplementary Products (collectively, ‘Minimum Purchase
Requirement’): 
  

					
	 Contract Year
	  	Minimum
Purchase
Requirement (%)	 
		
	 1/1/2015 - 12/31/2015
	  	 	[***]	% 
		
	 1/1/2016 - 12/31/2016
	  	 	[***]	% 
		
	 1/1/2017 - 12/31/2017
	  	 	[***]	% 
		
	 1/1/2018 - 12/31/2018
	  	 	[***]	% 
		
	 1/1/2019 - 12/31/2019
	  	 	[***]	% 

 If Customer makes any modifications, revisions, changes, variations or improvements to Key Products or
Supplementary Products (collectively, “Revisions”), all of such Revisions are included in the definition of Key Products and Supplementary Products, respectively, and are subject to the Minimum Purchase Requirement.” 

All other terms of Section 5 remain unchanged. 

5.) Exhibit A, Section 3. Exhibit A, Section 3, Definitions, of the First Amendment is hereby deleted in its entirety and
replaced with the following: 
 “3. Definitions. For purposes of this Agreement: 

(a) ‘Key Product(s)’ means percutaneous leads, lead extensions, S8 lead adaptors, M8 lead adaptors and lead proximal and sub-assembly
for paddle leads; 
 (b) ‘Supplementary Product(s)’ means the Cap Header, Part No. 10111-3, Rev J; Housing Set Screw Low Profile,
Part No. 10319, Rev C; and Arbor Press Assy, Part No. 10873, Rev B; and 
 (c) ‘Products’ means all Key Products and Supplementary
Products, together with active anchor inserts and other machined components, including, without limitation, set screw housings, set screws and IPG header caps.” 

  
 2. 

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

 6.) Exhibit A, Section 4. Exhibit A, Price Schedule, of the First Amendment is
deleted in its entirety and replaced with the following: 
 “4. Price Schedules and Adoption of Exhibits. The Parties hereby
adopt the Price Schedules, Exhibit B (attached to the First Amendment), Exhibit B-1 (attached to Second Amendment) and Exhibit B-2 (attached to Second Amendment) for all Products. For purposes of the Price Schedules, the Key Product Volumes
refer to the combined sum of all Key Products delivered during each Contract Year. 
 Additionally, no later than the last day of every
calendar quarter following the Effective Date of this Second Amendment, Stellar will provide Customer with an updated Price Schedule for the next calendar quarter (“Projection”), which will account for any changes, and Adjustments
including, but not limited to, changes in vendor costs, pricing for raw materials, and/or labor costs required for the manufacturing of the Products listed in Exhibit B, Exhibit B-1 and Exhibit B-2. Furthermore, Stellar will issue Customer an
invoice or a credit memo accounting for any variances resulting from changes to this Price Schedule during the calendar quarter directly preceding the Projection.” 

7.) Effective Dates of Exhibits B, B-1 and B-2. Exhibit B, Price Schedule for Key Products, expires December 31,
2015. Exhibit B-1, Price Schedule for Key Products, is effective January 1, 2016. Exhibit B-2, Price Schedule for Supplementary Products, is effective September 23, 2015. 

8.) Amendment to Quotations for Supplementary Products. 

The Parties amend the Quotations, Purchase Orders and Purchase Order Acknowledgments for the Supplementary Products, as follows: 

(a) Terms: NET 30, EXWORKS (INCOTERMS 2010) Stellar Loading Dock. 

(b) The Parties agree that the United Nations Convention on Contracts for the International Sale of Goods shall have no application to the
Agreement, this Second Amendment or any Quotations for Products (including, without limitation, Key Products and Supplementary Products) now or in the future. 

(c) For purposes of the Agreement and this Second Amendment, the current Quotations for the Supplementary Products are as follows: 

 

	 	•	 	Cap Header, Part No. 10111-3, Rev J, Quotation #013640-00, dated 9/23/2015; 

  

	 	•	 	Housing Set Screw Low Profile, Part No. 10319, Rev C, Quotation #013639-00, dated 9/23/2015; and 

  

	 	•	 	Arbor Press Assembly, Part No. 10873, Rev B, Quotation #013638-00, dated 9/23/2015. 

 (d) The
terms of the Agreement, as modified by this Second Amendment, supersede all inconsistent terms of the Quotations, Purchase Orders and Purchase Order Acknowledgments for Supplementary Products. 

 9.) Scope of Second Amendment. Subject only to the modifications of the Agreement
pursuant to this Second Amendment, the remainder of the Agreement has not been modified and otherwise remains in full force and effect. 

IN WITNESS WHEREOF, Customer and Stellar have executed this Second Amendment as of the Effective Date. 

 

													
	STELLAR TECHNOLOGIES, INC.,	 		 	NEVRO CORP., a Delaware corporation
	a Minnesota corporation	 		 		 	
					
	By:	 	 /s/ Estelle Forcelle
	 		 	By:	 	 /s/ Andrew Galligan

		 	Estelle Forcelle	 		 		 	Print Name:	 	Andrew Galligan
		 	Its:	 	Chief Executive Officer	 		 		 	Title:	 	Chief Financial Officer
					
	Date:	 	 1-28-16
	 		 	Date:	 	 1/25/2016

  
 4. 

 EXHIBIT B-1 

PRICE SCHEDULE FOR KEY PRODUCTS EFFECTIVE JANUARY 1, 2016 

This Price Schedule, Exhibit B-1, supersedes the Price Schedule, Exhibit B of the First Amendment, effective January 1, 2016, and governs the
purchase and sale of all Key Products delivered on or after January 1, 2016. 
  

									
	 	  	Key Product Volume*
	 Key Product
	  	[***]	  	[***]	 	  	[***]
				
	 Percutaneous Lead, Part Nos.:
	  	N/A	  				  	N/A
				
	 •  10160-3050B
	  		  	 	    [***]	  	  	
	 •  10160-5050B
	  		  	$	[***]	  	  	
	 •  10160-7050B
	  		  	$	[***]	  	  	
	 •  10160-9050B
	  		  	$	[***]	  	  	
				
	 Lead Extensions, Part Nos.:
	  	N/A	  				  	N/A
				
	 •  10169-25B
	  		  	$	[***]	  	  	
	 •  10169-35B
	  		  	$	[***]	  	  	
	 •  10169-60B
	  		  	$	[***]	  	  	
				
	 S8 Lead Adaptors, Part Nos.:
	  	N/A	  				  	N/A
				
	 •  10428-25B
	  		  	$	[***]	  	  	
				
	 M8 Lead Adaptors, Part Nos.:
	  	N/A	  				  	N/A
				
	 •  10433-35B
	  		  	$	[***]	  	  	
				
	 Lead Proximal and Sub-Assembly for Paddle Leads, Part Nos.:
	  	N/A	  				  	N/A
				
	 •  12017-5005
	  		  	$	[***]	  	  	
	 •  12017-7005
	  		  	$	[***]	  	  	
	 •  12017-9005
	  		  	$	[***]	  	  	

  

	*	Based on the combined number of all Key Products delivered during any Contract Year. All prices quoted and paid in USD ($US). 

NOTE: Prices do not include price of BAL seals. BAL seals to be charged to Nevro as a separate item. The price of BAL seals shall include a
reasonable premium or increase for BAL seals lost in the manufacturing process that cannot be reclaimed. 

  
 B-1 

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

 EXHIBIT B-2 

PRICE SCHEDULE FOR SUPPLEMENTARY PRODUCTS 

This Price Schedule, Exhibit B-2, governs the purchase and sale of all Supplementary Products, effective September 23, 2015. 

 

					
	 Supplementary Product
	  	Unit Price
$USD	 
		
	 Cap Header Part Nos.:
	  			
		
	 •  10111-3, Rev J
	  	US$	[***]	  
		
	 Housing Set Screw Low Profile Part Nos.:
	  			
		
	 •  10319, Rev C
	  	US$	[***]	  
		
	 Arbor Press Assembly Part Nos.:
	  			
		
	 •  10873, Rev B
	  	US$	[***]	  

 END 

  
 B-2 

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions.EX-10.5(c)

 Exhibit 10.5(c) 

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 
 SECOND AMENDMENT TO THE 

PRODUCT SUPPLY AND DEVELOPMENT AGREEMENT 

This SECOND AMENDMENT TO THE PRODUCT SUPPLY AND DEVELOPMENT AGREEMENT (“Amendment”), effective as of October 23, 2015 (the
“Effective Date”), is by and between EaglePicher Medical Power LLC (“EPMP LLC”), a Delaware Corporation having an address of “C” and Porter Streets, Joplin, MO 64801 and Nevro Corp. (“Buyer”), a Delaware
Corporation, having its principal place of business at 1800 Bridge Parkway, Redwood City, CA 94065. 
 WHEREAS, EPMP and Buyer entered into a Product Supply
and Development Agreement dated April 5, 2009 (“Agreement”) by which Buyer contracted EPMP to develop and manufacture batteries for proprietary medical implantable devices; 

WHEREAS, EPMP and Buyer wish to continue their relationship and modify portions of the Agreement; 

NOW, THEREFORE, EPMP LLC and Buyer hereby amend the Agreement as follows: 

Sections 4.1 shall be deleted in their entirety and replaced with the following section: 

4.0 ORDER AND DELIVERY. 
 4.1 The Buyer’s purchase
commitment shall consist of the quantity of Products for [***] (i.e., [***]) as identified in the table below (the “Buyer MPR”) with an invoicing and delivery schedule to be agreed upon by both EPMP and Buyer. For purposes of this
Agreement, estimated Buyer purchases are included for [***]. 
  

			
	 Year
	  	 [***]

	 Products
	  	[***]

 The following additional provisions shall apply: 
  

	 	•	 	January 1, 2015 – December 31, 2015 - A purchase order for at least the annual total quantity shown above for 2015 shall be issued by Buyer no later than five business days after the Effective Date.

  

	 	•	 	Notwithstanding anything else in this Section 4.1 or this Agreement, the Buyer MPR shall be satisfied when Buyer and its Subcontractors have collectively purchased a total of [***] Products. After such number of
Products has been purchased, there shall be no further minimum purchase requirements. For example, if Buyer purchases [***] Products in [***] and [***] Products in [***], the minimum purchase requirements under the Buyer MPR in [***] shall be
reduced to [***]. 

	 	•	 	A purchase order shall be issued by Buyer on or before [***] reflecting at least the minimum quantities for such years shown in the table above (subject to the last bullet below). Although Buyer shall maintain
responsibility for the Buyer MPR, Buyer 

  

	 	•	 	may satisfy all or part of the Buyer MPR through units purchased by Buyer’s subcontractor/vendor (e.g., [***]) (“Subcontractors”) as long as [***]. 

 

	 	•	 	On December 31st of each year, EPMP shall provide Buyer with an accounting of all of the quantities of Products purchased on behalf of Buyer by its Subcontractors during such year (“Third Party Quantities”).
To the extent that the Third Party Quantities and any direct purchases by Buyer (collectively, “Total Purchases”) have not together met the Buyer MPRs for the applicable calendar year, Buyer will be responsible for purchasing the
difference between the Total Purchases for such year and the Buyer MPRs for such year. 

  

	 	•	 	During any period after the Buyer MPR has been satisfied (including during [***]), Buyer and its Subcontractors may place Purchase Orders for Products in accordance with Section 4.3. 

 

	 	•	 	EPMP LLC shall maintain production capacity that can meet an additional [***] percent of the total units required by Buyer for each of the years during the term of this Agreement. For all the years shown above, if the
requirements exceed the above quantities by [***] percent, Buyer shall give at least [***] advance notice. 

 4.1.2 EPMP
LLC to establish a redundant battery production operation [***] projected to be fully qualified/validated [***]. EPMP/Buyer shall support as follows: 
  

	 	•	 	[***] to fund [***] 

  

	 	•	 	[***] to fund [***] ($[***]) and designate facility space for Nevro production (part of the long term commitment need) 

  

	 	•	 	[***] to fund [***] ($[***]) 

  

	 	•	 	[***] to fund [***] (~$[***]) 

  

	 	•	 	EP to maintain current production line until [***]. 

  

	 	•	 	EP to transfer and validate the current production line [***] 

  

	 	•	 	Buyer shall fund a portion of the replicate line equipment in the amount of [***] 

  

	 	•	 	The payments will be based on milestones and with [***] % at [***], [***]% upon [***], [***]% upon [***] 

  

	 	•	 	Buyer to meet or exceed annual purchase quantities for [***] in table above 

  

	 	•	 	The equipment purchased by Nevro is a [***] and [***] 

  

	 	•	 	Buyer to agree that EaglePicher Medical Power will be the exclusive battery supplier to Nevro for 5 years of supply agreement through 2019. 

  
 PRODUCT SUPPLY and DEVELOPMENT
AGREEMENT_Amendment #2 
 Page 2 of 7 
 [***]
Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 All other clauses of the Agreement remain unchanged and in full force and effect. 

IN WITNESS WHEREOF, the parties have caused this Amendment to be duly executed by their authorized representatives. 

 

			
	EAGLEPICHER MEDICAL POWER LLC
		
	By:	 	 /s/ Dave Lucero

		
	Name:	 	Dave Lucero
		
	Title:	 	Vice President & General Manager
		
	Date:	 	 11/6/2015

	
	NEVRO CORP.
		
	By:	 	 /s/ Andrew Galligan

		
	Name:	 	Andrew Galligan
		
	Title:	 	CFO, V.P. Finance
		
	Date:	 	 10/23/2015

  
 PRODUCT SUPPLY and DEVELOPMENT
AGREEMENT_Amendment #2 
 Page 3 of 7 

 Exhibit A 

Specifications 
 [Not
Amended] 

  
 PRODUCT SUPPLY and DEVELOPMENT
AGREEMENT_Amendment #2 
 Page 4 of 7 

 Exhibit B 

Non-Disclosure Agreement 

[Not Amended] 

  
 PRODUCT SUPPLY and DEVELOPMENT
AGREEMENT_Amendment #2 
 Page 5 of 7 

 Exhibit C 

(AMENDED) 
 Pricing Terms

  

									
	 Product Description
	  	Quantity	 	  	Unit
Price*	 
	 325mAh
	  	 	[***]	  	  	$	[***]	  
	 325mAh
	  	 	[***]	  	  	$	[***]	  
	 325mAh
	  	 	[***]	  	  	$	[***]	  

  

	*	The Unit Price is tiered (i.e., if Buyer purchases in a calendar year an amount equal to or greater than a quantity specified above, the unit price for all units purchased during such year shall be unit price for the
last unit purchased in such year). For example, if Buyer purchases [***] units in a year, the unit price for all units purchased during such year will be $[***]. For years when the Buyer MPR is in effect, the highest unit price for any unit
purchased during such year shall be the unit price applicable to the minimum required Purchase Order quantity or such year (i.e., if the Buyer MPR requires [***] units to be purchased in a year, the unit price of all units ordered that year,
including under the initial Purchase Orders, shall be $[***]). For years when the Buyer MPR is not in effect, the parties will do a true up calculation at the end of the year, and if applicable EPMP shall refund to Buyer or its designee the amount
necessary to ensure that the average unit price for all units purchased during that year is equal to the lowest unit price applicable to any unit purchased during that year. 

  

			
	PRODUCT SUPPLY and DEVELOPMENT AGREEMENT_Amendment #1	 	Page 6 of 7

 [***] Certain information in this document has been omitted and filed separately
with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 Exhibit D 

Development Plan(s) 

[Not Amended] 

  

			
	PRODUCT SUPPLY and DEVELOPMENT AGREEMENT_Amendment #1	 	Page 7 of 7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}]]